Search results
Start date:
Feb 05, 2025
This one-hour session provides a concise and practical overview of hemolysis including its pathophysiology, detection and clinical consequences. Gain actionable insights into hemolysis and PFA technologies through a review of preclinical data as well as real-world strategies for patient selection and procedural optimization.Moderated by Dr Nishaki Mehta (Corewell William Beaumont University…
View more
Added:
2 years ago
In this engaging video series, we are joined by an esteemed faculty, co-chaired byDr Claire Martin(Royal Papworth Hospital, UK) andProf Josef Kautzner(Charles University Medical School, Czech Republic) who will present and discuss a series of topics surrounding the clinical evidence behind pulsed field ablation (PFA).
Dr Vivek Reddy(The Mount Sinai Hospital, US) andDr Boris Schmidt(Centrum…
View more
Added:
4 days ago
Added:
4 days ago
Start date:
Nov 07, 2025
Real-world perspectives from PulseSelect™ and Affera™With lots of new pulsed-field ablation (PFA) technology becoming available, the most important question becomes: How are they performing in the real-world? This session will dive into the lab to share practical perspectives from physicians at the forefront of adoption. Join Dr Jack McCready(University Hospitals Sussex NHS Foundation Trust, UK)…
View more
Added:
2 months ago
ESC Congress 2025 - FARADISE Registry finds FARAPULSE™ pulsed field ablation (PFA) system safe and easy to use, with an 80% clinical effectiveness at one year in paroxysmal AF.Prof Lucas Boersma (St Antonius Hospital, Nieuwegein, NL) joins us to discuss one-year findings from the observational, prospective, single-arm FARADISE global registry (NCT05501873) which collected real-world data from up…
View more
Added:
3 months ago
Source:
Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained…
View more
Added:
1 year ago
Prof. Chierchia & Dr. Della Rocca share their perspectives on the PERFECT-PAF trial, which evaluates the clinical safety and economic value of FARAPULSETM PFA compared to cryoablation (CBA). In the interview, they highlight the study's design and key findings, along with its impact on clinical practice.
View more
Added:
1 year ago
How does the FARAPULSE cell selective energydelivery with an optimised workflow and purpose-built catheter translate to clinical practice? Dr YuriBlaauw discusses how FARAPULSE has changed hisclinical practice and hospital workflow. Thepredictable procedure times with FARAPULSE PFAhave allowed for treatment of more patients per day.Learn from him how this has also impacted hishospital capacity…
View more
Conduction System Pacing: A Fresh Look
Video Series